Targeting the interleukin‐11 receptor α in metastatic prostate cancer: A first‐in‐man study

E-ISSN： 1097-0142|121|14|2411-2421

ISSN： 0008-543x

Source： CANCER, Vol.121, Iss.14, 2015-07, pp. : 2411-2421

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

The Role of an Androgen Receptor Polymorphism in the Clinical Outcome of Patients with Metastatic Prostate Cancer

Urologia Internationalis, Vol. 68, Iss. 1, 2002-01 ,pp. : 16-23

Karger

Access to resources Recommend Favorite

Interleukin-1α Enhances Integrin α₆β₁ Expression and Metastatic Capability of Human Pancreatic Cancer

Oncology, Vol. 65, Iss. 2, 2003-08 ,pp. : 167-173

Karger

Access to resources Recommend Favorite

Treatment of metastatic prostate cancer

TRENDS IN UROLOGY AND MEN'S HEALTH, Vol. 6, Iss. 4, 2015-07 ,pp. : 7-12

John Wiley & Sons Inc

Access to resources Recommend Favorite

First‐in‐man study of ACT‐453859, a potent CRTH2 antagonist—Is the metabolite formation influenced by a polymorphic enzyme?

JOURNAL OF CLINICAL PHARMACOLOGY (ELECTRONIC), Vol. 55, Iss. 12, 2015-12 ,pp. : 1432-1432

John Wiley & Sons Inc

Access to resources Recommend Favorite

First‐in‐Man Study of Dedicated Bifurcation Sirolimus‐eluting Stent: 12‐month Results of BiOSS LIM® Registry

JOURNAL OF INTERVENTIONAL CARDIOLOGY, Vol. 28, Iss. 1, 2015-02 ,pp. : 51-60

John Wiley & Sons Inc

Access to resources Recommend Favorite